Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial
Public ClinicalTrials.gov record NCT02061280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02061280
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Nemours Children's Clinic
- Other
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- fluticasone/salmeterol 250/50 Dry Powder Inhaler Drug
- fluticasone/salmeterol 100/50 Dry Powder Inhaler Drug
- fluticasone 100mcg Dry Powder Inhaler Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Feb 16, 2017
- Completion
- Feb 16, 2017
- Last update posted
- Dec 18, 2018
2013 – 2017
United States locations
- U.S. sites
- 5
- U.S. states
- 3
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alfred I. duPont Hospital for Children | Wilmington | Delaware | 19803 | — |
| Nemours Children's Specialty Care | Jacksonville | Florida | 32207 | — |
| Nemours Children's Hospital | Orlando | Florida | 32806 | — |
| Nemours Children's Specialty Care | Pensacola | Florida | 32504 | — |
| Washington University in St. Louis | St Louis | Missouri | 63130 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02061280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2018 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02061280 live on ClinicalTrials.gov.